ALDEYRA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

ALDEYRA THERAPEUTICS, INC. (ALDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $1.80 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-23.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2015-03-23

ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2014 was $1.80M, a 63.64% increase from fiscal 2013.
ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2013 was $1.10M.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 0 month	Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month
2014-12-31		$1.80M 10-K · filed 2015-03-23
2013-12-31		$1.10M 10-K · filed 2015-03-23
2013-09-08	$221.00K 10-K · filed 2015-03-23

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41
Lunai Bioworks Inc. (LNAI)	United States	$0.072B	-0.11
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
PMV Pharmaceuticals, Inc. (PMVP)	United States	$0.071B	-0.95
TENAX THERAPEUTICS, INC. (TENX)	United States	$0.071B	-7.17
PLIANT THERAPEUTICS, INC. (PLRX)	United States	$0.071B	-0.76
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30